Advertisement

Chronobiotechnology and Chronobiological Engineering

  • Lawrence E. Scheving
  • Franz Halberg
  • Charles F. Ehret

Part of the NATO ASI Series book series (NSSE, volume 120)

Table of contents

  1. Front Matter
    Pages I-XXII
  2. Perspectives in Chronobiology and Modern Drug Administration Devices

  3. Analysis of Time Series Data

  4. Chronology of Instrumentation for Body Temperature Monitoring

    1. Lawrence E. Scheving, Franz Halberg, Charles F. Ehret
      Pages 141-188
  5. “State of the Art” in the Monitoring of Rhythms in Psychological Functions and Motor Activity

    1. D. P. Redmond, F. W. Hegge
      Pages 202-215
  6. Monitoring and Quantification of Eye-Movements of REM sleep

  7. Instrumentation and Data Analysis Methods Needed for Blood Pressure Monitoring in Chronobiology

    1. Michael A. Weber, J. I. M. Drayer, D. D. Brewer
      Pages 270-277
    2. Paul J. Meis, Franz Halberg, Frances Boyette-Kouri
      Pages 278-281
    3. Erna Halberg, Franca Carandente, Robert B. Sothern, Franz Halberg
      Pages 289-298
    4. P. T. Scarpelli, S. Romano, R. Livi, L. Scarpelli, G. Cornélissen, M. Cagnoni et al.
      Pages 304-309
  8. Circadian and Ultradian Monitoring of the Cardiovascular System

    1. Charles N. Leach Jr.
      Pages 318-326
  9. “State of the Art” Monitoring of Chronobiotechnology and Chronobiological Engineering in Laboratory Medicine

  10. Data Acquisition Systems for Studies of Rhythms in Animals

    1. Kenneth R. Groh, Charles F. Ehret, William J. Eisler Jr., Donald A. LeBuis
      Pages 397-405
    2. D. K. Hayes, R. W. Miller, H. Jaffe
      Pages 429-432
    3. L. Jonsson, O. Sand
      Pages 432-434
  11. Back Matter
    Pages 435-453

About this book

Introduction

High blood pressure (BP) (with fats and smoking) is one of the three roots of cardio-cerebro-renovascular disease affecting up to 25% of the adult population. Hence, high blood pressure should be recognized and treated, to reduce any complications and prolong life, as noted by Michael Weber of the Veterans Administration Hospital in Long Beach, California. He further emphasizes the need for monitoring before one starts the treatment of high blood pressure. Indeed, he refers to the results of the Australian study on mild hypertension with a large percentage of placebo­ responders and rightly suggests that many people are treated who should not be because of 'white-coat-associated high blood pressure'. He also points to the lack of standardization of techniques for data analysis and of methods of BP measurement. Ambulatory monitoring under usual condi­ tions without concomitant recording of events does not allow even a qualitative assessment of the impact of varying stimuli, in weber's opinion.

Keywords

bioengineering biotechnology cardiovascular system drug drug delivery electrocardiogram (ECG) laboratory medicine medicine neuropharmacology pharmacology pregnancy research therapy treatment

Editors and affiliations

  • Lawrence E. Scheving
    • 1
  • Franz Halberg
    • 2
  • Charles F. Ehret
    • 3
  1. 1.University of Arkansas for Medical SciencesLittle RockUSA
  2. 2.University of Minnesota School of MedicineMinneapolisUSA
  3. 3.Argonne National LaboratoriesArgonneUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-94-009-3547-1
  • Copyright Information Springer Science+Business Media B.V. 1987
  • Publisher Name Springer, Dordrecht
  • eBook Packages Springer Book Archive
  • Print ISBN 978-94-010-8086-6
  • Online ISBN 978-94-009-3547-1
  • Series Print ISSN 0168-132X
  • Buy this book on publisher's site
Industry Sectors
Pharma
Health & Hospitals
Biotechnology
Consumer Packaged Goods